[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100543882":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":35,"responsibleParty":90,"collaborators":11,"id":92,"slug":93,"hasResults":94,"nctId":95,"briefTitle":96,"officialTitle":97,"acronym":98,"eligibilityCriteria":99,"healthyVolunteers":94,"sex":100,"minAge":101,"maxAge":11,"enrollmentInfo":102,"targetDuration":11,"studyType":105,"phases":106,"briefSummary":108,"conditions":109,"keywords":11,"overallStatus":38,"whyStopped":11,"lastUpdateSubmitDate":114,"lastUpdatePostDateStruct":115,"startDateStruct":118,"completionDateStruct":120,"leadSponsor":122,"locationsCount":123},{"fullName":5,"class":6},"University Hospital, Angers","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Phemop Cohort","EXPERIMENTAL",null,[13],"Diagnostic Test: Monocytes signatures in myeloproliferative neoplasms at diagnosis",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DIAGNOSTIC_TEST","Monocytes signatures in myeloproliferative neoplasms at diagnosis","The monocytes signatures will be perform from a peripheral blood sample. The signature will be derived from (i) surface marker expression, (ii) cytokines profiles, (iii) genes expression.",[9],[21],{"name":22,"affiliation":23,"role":24},"Agathe GOUBAND, PharmD","University Hospital","PRINCIPAL_INVESTIGATOR",[26,31],{"name":22,"role":27,"phone":28,"phoneExt":29,"email":30},"CONTACT","02 41 35 55 96","33","Agathe.Gouband@chu-angers.fr",{"name":32,"role":27,"phone":33,"phoneExt":29,"email":34},"UH Angers DRCI","+ 33 2 41 35 54 96","DRCI-Promotion-Interne@chu-angers.fr",[36,58,75],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"GOUBAND Agathe","RECRUITING","Angers","Maine et Loire","49933","France","FR",{"type":45,"coordinates":46},"Point",[47,48],-0.55202,47.47156,{"lat":48,"lon":47},[51,52,56],{"name":22,"role":27,"phone":28,"phoneExt":29,"email":30},{"name":53,"role":27,"phone":54,"phoneExt":29,"email":55},"Damien LUQUE PAZ, PharmD","02 41 35 53 53","Damien.LuquePaz@chu-angers.fr",{"name":57,"role":24,"phone":11,"phoneExt":11,"email":11},"Corentin ORVAIN, MD",{"facility":59,"status":60,"city":61,"state":40,"zip":62,"country":42,"countryCode":43,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"BESCOND Charles","NOT_YET_RECRUITING","Cholet","49325",{"type":45,"coordinates":64},[65,66],-0.87974,47.05893,{"lat":66,"lon":65},[69,73],{"name":70,"role":27,"phone":71,"phoneExt":11,"email":72},"Charles BESCOND, MD","0241355880","charles.bescond@ch-cholet.fr",{"name":74,"role":24,"phone":11,"phoneExt":11,"email":11},"Charles Bescond, MD",{"facility":76,"status":60,"city":77,"state":40,"zip":78,"country":42,"countryCode":43,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"TRUCHAN-GRACZYK Malgorzata","Saumur","49400",{"type":45,"coordinates":80},[81,82],-0.07808,47.25931,{"lat":82,"lon":81},[85,89],{"name":86,"role":27,"phone":87,"phoneExt":29,"email":88},"Malgorzata TRUCHAN-GRACZYK, MD","0241533544","matruchan@ch-saumur.fr",{"name":86,"role":24,"phone":11,"phoneExt":11,"email":11},{"type":91,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100543882","functional-and-phenotypic-characterization-of-monocytes-in-myeloproliferative-syndromes-100543882",false,"NCT06361641","Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes","Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes-PHEMOP","PHEMOP","Inclusion Criteria:\n\n* Diagnosis of PV, ET, pre-myelofibrosis or primary myelofibrosis according to WHO 2022 criteria (including BOM for ET, premyelofibrosis and primary myelofibrosis)\n* Patient who has not received treatment specific to hemopathy at the time of sampling\n* Obtaining the signature of consent to participate in the study\n* Patient having consented to be included in the \"Malignant Hemopathy\" collection of Angers University Hospital and in FIMBANK database\n\nExclusion Criteria:\n\n* Person not affiliated to a social security scheme or beneficiary of such a scheme\n* Patient with another hemopathy or another active cancer at the time of diagnosis\n* Minor patient at diagnosis (\\\u003C 18 years old)\n* Patient not capable or without agreement from the guardian or legal representative","ALL","18 Years",{"count":103,"type":104},70,"ESTIMATED","INTERVENTIONAL",[107],"NA","Prospective study for functional and phenotypic characterization of monocytes in philadelphia-negative myeloproliferative neoplasms",[110,111,112,113],"Myeloproliferative Neoplasm","Polycythemia Vera","Essential Thrombocythemia","Primary Myelofibrosis","2025-12-02",{"date":116,"type":117},"2025-12-08","ACTUAL",{"date":119,"type":117},"2024-05-29",{"date":121,"type":104},"2028-10-19",{"name":5,"class":6},3]